Pertussis continues to be a significant cause of morbidity and mortality among
nonimmunized young infants. Although the inception of childhood pertussis immunization …

Abstract In North America, children currently receive 5 doses of a combined diphtheria-
tetanus-acellular pertussis vaccine between the ages of 2 months and 6 years. Although this …

Despite widespread immunization programs in most countries, pertussis disease continues
to be a threat to public health. In particular, there has been a resurgence of pertussis …

Background: Pertussis, or whooping cough, is a bacterial disease characterized by
paroxysmal cough often accompanied by inspiratory whoop and posttussive emesis …

Despite high vaccination coverage, over the last fifteen years there has been a worldwide
resurgence of B. pertussis infection. While classical pertussis in the prevaccine era was …

Abstract Background. The Global Pertussis Initiative, an expert scientific forum, was
established to address the ongoing problems associated with pertussis disease worldwide …

Universal pertussis vaccination has successfully decreased pertussis mortality and morbidity
in childhood. However, despite intensive vaccination of young children, pertussis remains a …

Background: The reported incidence of pertussis is increasing, especially among the
adolescent population. Current outbreak management strategies include investigating …

In countries with high rates of vaccination against pertussis, the incidence of this disease
has decreased dramatically compared with the prevaccine era. However, pertussis still …

BACKGROUND: Pertussis remains a cause of considerable morbidity in children worldwide.
Due to the resurgence of the disease, two vaccine doses for schoolchildren were added to …